Novo Nordisks oral Wegovy, approved in December 2025, was the first oral GLP-1 to hit the obesity market
Some people may take tirzepatide while using blood pressure medication, but this should be supervised by a healthcare provider
The American Diabetes Association has responded by recommending lower BMI cutoffs of 23 or higher for diabetes screening in Asian American populations
Here are some practical steps to consider: Monitor Retinal Health : Ensure that patients on GLP-1 medications receive regular eye exams, particularly if they have a history of diabetic retinopathy
This therapy is designed to regulate appetite, boost metabolism, and support fat loss, all while preserving lean muscle mass
Histologically, congenital hyperinsulinism can be diffuse, where all beta cells are affected, or focal, where there is a focal area of adenomatosis ( Plasma incretin concentrations in both the fasting and fed state have been measured in patients with different forms of congenital hyperinsulinism
